---
layout: page
title: Publications
subtitle: 
---

# Accepted papers

1. Dmitrienko, A., Millen, B. A., Brechenmacher, T., & **Paux, G.** (2011). [Development of gatekeeping strategies in confirmatory clinical trials](https://doi.org/10.1002/bimj.201100036). In Biometrical Journal (Vol. 53, Issue 6, pp. 875–893). Wiley. 
2. Dmitrienko, A., **Paux, G.**, & Brechenmacher, T. (2015). [POWER CALCULATIONS IN CLINICAL TRIALS WITH COMPLEX CLINICAL OBJECTIVES](https://doi.org/10.5183/jjscs.1411001_213). In Journal of the Japanese Society of Computational Statistics (Vol. 28, Issue 1, pp. 15–50). Japanese Society of Computational Statistics. 
3. Dmitrienko, A., **Paux, G.**, Pulkstenis, E., & Zhang, J. (2015). [Tradeoff-based optimization criteria in clinical trials with multiple objectives and adaptive designs](https://doi.org/10.1080/10543406.2015.1092032). In Journal of Biopharmaceutical Statistics (Vol. 26, Issue 1, pp. 120–140). Informa UK Limited. 
4. Petroni, G. R., Wages, N. A., **Paux, G.**, & Dubois, F. (2016). [Implementation of adaptive methods in early‐phase clinical trials](https://doi.org/10.1002/sim.6910). In Statistics in Medicine (Vol. 36, Issue 2, pp. 215–224). Wiley. 
5. **Paux, G.**, & Dmitrienko, A. (2017). [Penalty-based approaches to evaluating multiplicity adjustments in clinical trials: Traditional multiplicity problems](https://doi.org/10.1080/10543406.2017.1397010). In Journal of Biopharmaceutical Statistics (Vol. 28, Issue 1, pp. 146–168). Informa UK Limited. 
6. **Paux, G.**, & Dmitrienko, A. (2017). [Penalty-based approaches to evaluating multiplicity adjustments in clinical trials: Advanced multiplicity problems](https://doi.org/10.1080/10543406.2017.1397011). In Journal of Biopharmaceutical Statistics (Vol. 28, Issue 1, pp. 169–188). Informa UK Limited. 
7. Quan, H., Chen, X., Lan, Y., Luo, X., Kubiak, R., Bonnet, N., & **Paux, G.** (2020). [Applications of Bayesian analysis to proof‐of‐concept trial planning and decision making](https://doi.org/10.1002/pst.1985). In Pharmaceutical Statistics (Vol. 19, Issue 4, pp. 468–481). Wiley. 
8. Quan, H., Xu, Z., Luo, J., **Paux, G.**, Cho, M., & Chen, X. (2023). [Utilization of treatment effect on a surrogate endpoint for planning a study to evaluate treatment effect on a final endpoint](https://doi.org/10.1002/pst.2298). In Pharmaceutical Statistics (Vol. 22, Issue 4, pp. 633–649). Wiley. 

# Book chapters

1. Dmitrienko, A., & **Paux, G.** (2017). [Clinical Scenario Evaluation and Clinical Trial Optimization](https://doi.org/10.1201/9781315120836-1). In Clinical Trial Optimization Using R (pp. 1–69). Chapman and Hall/CRC. 
2. Dmitrienko, A., & **Paux, G.** (2017). [Clinical Trials with Multiple Objectives](https://doi.org/10.1201/9781315120836-2). In Clinical Trial Optimization Using R (pp. 71–172). Chapman and Hall/CRC. 
3. Dmitrienko, A., & **Paux, G.** (2017). [Subgroup Analysis in Clinical Trials](https://doi.org/10.1201/9781315120836-3). In Clinical Trial Optimization Using R (pp. 173–250). Chapman and Hall/CRC. 

